Compare CGEM & JBSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CGEM | JBSS |
|---|---|---|
| Founded | 2016 | 1959 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Specialty Foods |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 904.7M | 913.0M |
| IPO Year | 2020 | 1994 |
| Metric | CGEM | JBSS |
|---|---|---|
| Price | $16.18 | $74.51 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 1 |
| Target Price | $30.13 | ★ $109.00 |
| AVG Volume (30 Days) | ★ 778.1K | 90.9K |
| Earning Date | 05-11-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 3.26% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 4.55 |
| Revenue | N/A | ★ $1,107,246,000.00 |
| Revenue This Year | N/A | $5.58 |
| Revenue Next Year | $5.20 | N/A |
| P/E Ratio | ★ N/A | $16.75 |
| Revenue Growth | N/A | ★ 3.79 |
| 52 Week Low | $5.68 | $59.07 |
| 52 Week High | $16.74 | $85.15 |
| Indicator | CGEM | JBSS |
|---|---|---|
| Relative Strength Index (RSI) | 65.46 | 36.37 |
| Support Level | $11.92 | $74.24 |
| Resistance Level | N/A | $84.04 |
| Average True Range (ATR) | 1.02 | 3.16 |
| MACD | 0.27 | -0.59 |
| Stochastic Oscillator | 92.55 | 1.97 |
Cullinan Therapeutics Inc is a clinical-stage biopharmaceutical company developing therapies for autoimmune diseases and cancer. Its development pipeline comprises the following drug candidates: CLN-978, a CD19xCD3 bispecific T cell engager that is being developed for autoimmune diseases; CLN-049, a FLT3xCD3 bispecific T cell engager being evaluated in an ongoing clinical trial in patients with relapsed/refractory acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS); Velinotamig, a BCMAxCD3 bispecific T cell engager being developed to counter autoimmune diseases; and Zipalertinib, being developed as a treatment for non-small cell lung cancer. Additionally, the company is developing several preclinical programs in autoimmune diseases and oncology.
John B Sanfilippo & Son Inc is one of the processors and distributors of peanuts, pecans, cashews, walnuts, almonds, and other nuts in the United States. These nuts are sold under a variety of private brands and the Fisher, Orchard Valley Harvest, and Sunshine Country brand names. It also markets and distributes, and in the majority of cases, manufactures or processes, a diverse product line of food and snack products, including peanut butter, almond butter, cashew butter, candy and confections, snacks and trail mixes, snack bites, sunflower kernels, dried fruit, corn snacks, sesame sticks and other sesame snack products under private brands and brand names.